International audienceThe recent development of novel model systems for the early steps of hepatitis C virus (HCV) infection has rapidly advanced our knowledge of antibody-mediated virus neutralization in patients with acute and chronic hepatitis C. This review summarizes our current understanding of host neutralizing responses during the course of HCV infection. It focuses on recent studies in HCV-infected patients investigating the role of antibody responses for viral clearance as well as the mechanisms of viral escape from virus neutralizing antibodies during progression into chronic infection. Moreover, the potential impact of virus neutralizing antibodies for the development of novel preventive and therapeutic antiviral strategies is d...
Hepatitis C virus (HCV) represents a major public health problem, affecting 3% of the world’s popula...
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease worldwide. The interplay...
The precise role of adaptive immune responses in the clinical outcome of HCV infection is still only...
International audienceThe recent development of novel model systems for the early steps of hepatitis...
International audienceThe recent development of novel model systems for the early steps of hepatitis...
International audienceThe recent development of novel model systems for the early steps of hepatitis...
International audienceThe recent development of novel model systems for the early steps of hepatitis...
International audienceThe recent development of novel model systems for the early steps of hepatitis...
International audienceThe recent development of novel model systems for the early steps of hepatitis...
International audienceHepatitis C virus (HCV) is a major cause of hepatitis world-wide. The majority...
International audienceHepatitis C virus (HCV) is a major cause of hepatitis world-wide. The majority...
International audienceHepatitis C virus (HCV) is a major cause of hepatitis world-wide. The majority...
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease worldwide. The interplay...
Hepatitis C virus (HCV) represents a major public health problem, affecting 3% of the world’s popula...
AbstractHepatitis C virus (HCV) is a major cause of liver disease and hepatocellular carcinoma world...
Hepatitis C virus (HCV) represents a major public health problem, affecting 3% of the world’s popula...
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease worldwide. The interplay...
The precise role of adaptive immune responses in the clinical outcome of HCV infection is still only...
International audienceThe recent development of novel model systems for the early steps of hepatitis...
International audienceThe recent development of novel model systems for the early steps of hepatitis...
International audienceThe recent development of novel model systems for the early steps of hepatitis...
International audienceThe recent development of novel model systems for the early steps of hepatitis...
International audienceThe recent development of novel model systems for the early steps of hepatitis...
International audienceThe recent development of novel model systems for the early steps of hepatitis...
International audienceHepatitis C virus (HCV) is a major cause of hepatitis world-wide. The majority...
International audienceHepatitis C virus (HCV) is a major cause of hepatitis world-wide. The majority...
International audienceHepatitis C virus (HCV) is a major cause of hepatitis world-wide. The majority...
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease worldwide. The interplay...
Hepatitis C virus (HCV) represents a major public health problem, affecting 3% of the world’s popula...
AbstractHepatitis C virus (HCV) is a major cause of liver disease and hepatocellular carcinoma world...
Hepatitis C virus (HCV) represents a major public health problem, affecting 3% of the world’s popula...
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease worldwide. The interplay...
The precise role of adaptive immune responses in the clinical outcome of HCV infection is still only...